# UK Catheters Active Implantable CDMO Market > UK Catheters Active Implantable CDMO Market Research Report By Service Category (Catheters, Active Implantable Devices, Endoscopy Devices, Others) andBy End-Users (Medical Device OEM Companies, Academic and Research Institutes, Government Agencies) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 11.17% - **2024:** $ 280.88 Million - **2025:** $ 312.25 Million - **2035:** $ 900 Million - **Key Players:** Medtronic (US), Boston Scientific (US), Abbott (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Cook Medical (US), Terumo Corporation (JP), Smiths Medical (US), Halyard Health (US) **Report ID:** MRFR/MED/48369-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/uk-catheters-active-implantable-cdmo-market-50126 --- ## Market Summary ## **UK Catheters Active Implantable CDMO Market Overview** As per MRFR analysis, the UK Catheters Active Implantable CDMO Market Size was estimated at 311.85 (USD Million) in 2023.The UK Catheters Active Implantable CDMO Market Industry is expected to grow from 337.05(USD Million) in 2024 to 1,128.05 (USD Million) by 2035. The UK Catheters Active Implantable CDMO Market CAGR (growth rate) is expected to be around 11.608% during the forecast period (2025 - 2035). ## **Key UK Catheters Active Implantable CDMO Market Trends Highlighted** The UK Catheters Active Implantable CDMO Market is undergoing several critical shifts which corresponds with the changing demands and expectations in healthcare. One of the fundamental drivers of the market is the greater adoption and prevalence of chronic diseases which tend to drive greater demand for more useful and effective medical devices thus innovating and expanding the industry. Moreover, the government in the UK has focused on the need for improving patient care services which can be implemented with more sophisticated healthcare tools and approaches leading to an aggressive expansion of catheter related products.  In addition, there is a greater need to improve surgical results and enhance the recovery rate which is turning to be more favorable for R&D investment. This is beneficial for new entrants as well as existing players in the market. Lately, there has been a significant movement towards bespoke solutions in the catheter segment, where healthcare providers are looking for specialized products for specific patients. This advancement in customization is aided by improvements in materials and manufacturing technologies that enable the production of more sophisticated goods. Additionally, infection control awareness is becoming more prevalent and is encouraging manufacturers to add antimicrobial technologies to their products, which is becoming the norm among British healthcare practitioners. Underdeveloped areas include partnerships between CDMOs and primary research focusing on the design of new innovative catheters that meet the changing demands of the UK healthcare system. There is also potential for expansion into new areas of telemedicine and home care services as they relate to catheter use. The sustainability movement is also impacting the market, targeting the use of sustainable materials and processes in healthcare, which is consistent with the UK healthcare system's overall environmental reduction initiative. This situation demonstrates an innovative and fast-evolving market with increasing prospects for development. ## **UK Catheters Active Implantable CDMO Market Drivers** Increasing Prevalence of Chronic Diseases The rising incidence of chronic diseases such as cardiovascular disorders and diabetes in the UK is driving growth in the UK Catheters Active Implantable Contract Development and Manufacturing Organization (CDMO) Market. According to Public Health England, over 4 million people are living with diabetes in the UK, a number that has risen significantly in recent years. Furthermore, the National Health Service (NHS) indicates that cardiovascular diseases account for one in four deaths in the UK. This surge in chronic conditions necessitates advanced medical devices like catheters, thereby propelling the need for more specialized manufacturing and development services within the CDMO sector. Established organizations, such as Medtronic and Boston Scientific, are now ramping up their Research and Development initiatives in the UK to meet this growing demand for catheter technologies and innovate treatments for chronic diseases. Technological Advancements in Medical Devices Innovations in medical technologies are a significant driver for the UK Catheters Active Implantable CDMO Market Industry. The UK is home to various leading medical research institutions and organizations, including the University of Cambridge and Imperial College London, which are pioneering new catheter technologies. Recent advancements such as biocompatible materials, minimally invasive procedures, and telehealth integrations are making catheters more effective and safer for patients. The Department of Health and Social Care in the UK has recognized these advancements, noting an increased investment of around 20% in medical equipment technologies over the last five years. Such developments not only enhance patient outcomes but also stimulate demand within the CDMO market sector, encouraging manufacturers to collaborate with research institutions. Regulatory Support and Quality Standards The UK government has implemented favorable regulatory frameworks that support innovation and quality improvements in the medical device sector, including catheters. The Medicines and Healthcare products Regulatory Agency (MHRA) provides clear guidelines and accelerates the approval process for new catheter technologies, making it easier for CDMOs to bring products to market. Recent reports indicate that the MHRA has expedited the approval timelines by 30% for innovative medical devices. This regulatory encouragement leads to a more robust environment for manufacturers and contributes to the growth of the UK Catheters Active Implantable CDMO Market. Established companies, such as Smith & Nephew, are responding to these regulations by enhancing their quality management systems to comply with higher standards required by the MHRA. Rising Geriatric Population The aging population in the UK is prompting an increase in demand for medical devices, particularly catheters that cater to age-related health issues. According to the Office for National Statistics, it is projected that by 2040, approximately 24% of the UK population will be aged 65 and over, compared to 18% in 2020. This demographic transition leads to increased prevalence of conditions necessitating catheter use, such as urinary incontinence and cardiovascular diseases. Consequently, CDMOs are expected to scale their operations to meet this demographic shift, ensuring they can fulfill the rising demand for catheter devices. Companies like B. Braun and Coloplast are already adapting their product lines and manufacturing strategies to target the growing needs of the elderly population in the UK. ## **UK Catheters Active Implantable CDMO Market Segment Insights** ### **Catheters Active Implantable CDMO Market Service Category Insights** The UK [Catheters Active Implantable CDMO](../../../reports/catheters-active-implantable-cdmo-market-26788) Market, particularly within the Service Category, shows a diverse range of offerings that are pivotal in enhancing healthcare solutions. This sector primarily encompasses various areas, including Catheters, Active Implantable Devices, Endoscopy Devices and others, each contributing significantly to the overall market dynamics. The Catheters segment is essential as it addresses a myriad of medical needs, specifically in patient care associated with cardiovascular, urinary, and gastrointestinal issues, where regular and efficient access to blood vessels, urine flow, or bodily cavities is crucial for treatment protocols.  Moreover, Active Implantable Devices play a vital role by enabling long-term functionality for patient health, as these devices are often utilized in critical applications, including cardiac rhythm management and neurological support. Endoscopy Devices represent an important aspect of diagnostic and therapeutic procedures, enhancing the ability of healthcare professionals to perform minimally invasive surgeries. These devices have been instrumental in improving patient outcomes due to their efficiency and effectiveness in various treatments, thus steadily gaining a larger share of the market.  The overall growth within the Service Category is driven by advancements in technology, increasing chronic disease prevalence, and rising patient demand for minimally invasive solutions. Additionally, the regulatory landscape in the UK promotes strict quality standards, ensuring that the products in these segments are of high quality, which further supports market growth. Furthermore, the UK healthcare system continually emphasizes patient-centric approaches, which steer the development of innovative solutions within these segments, catering to the evolving needs of patients and healthcare providers alike. As a result, the Service Category remains a crucial aspect of the UK Catheters Active Implantable CDMO Market, intertwined with ongoing advancements and the holistic improvement of patient care across the region. ### **Catheters Active Implantable CDMO Market End-Users Insights** The UK Catheters Active Implantable CDMO Market showcases diverse End-Users, notably Medical Device Original Equipment Manufacturer Companies, Academic and Research Institutes, and Government Agencies. Medical Device OEM Companies play a crucial role as they seek innovative partnerships with Contract Development and Manufacturing Organizations (CDMOs) to enhance product development and streamline their supply chain processes.  Academic and Research Institutes significantly contribute to the market by driving Research and Development efforts, focusing on advancing medical technology and improving patient outcomes through innovative catheter designs and applications.Government Agencies also hold a pivotal position in the ecosystem by enforcing regulations that ensure the safety and efficacy of medical devices, thereby maintaining public trust in healthcare solutions.  As the healthcare landscape in the UK continues to evolve, these End-Users will be integral in shaping advancements within the UK Catheters Active Implantable CDMO Market, leveraging collaboration and innovation to meet increasing healthcare demands. The integration of technology and regulatory frameworks aids in improving patient care, establishing a significant link between the End-Users and market dynamics. **UK Catheters Active Implantable CDMO Market Key Players and Competitive Insights:** The UK Catheters Active Implantable CDMO Market is a dynamic sector characterized by rapid advancements in medical technologies, increasing demand for minimally invasive procedures, and a growing focus on patient-centric solutions. This market comprises numerous contract development and manufacturing organizations that play a pivotal role in the design, development, and production of catheter-based devices catering to various medical needs. With a rising emphasis on quality and regulatory compliance, as well as the growing trend of outsourcing manufacturing processes, the competitive landscape is evolving with key players striving to enhance their market positions through innovation and strategic partnerships.  These developments are also driven by an aging population and the prevalence of chronic diseases, which are catalyzing the need for more advanced and effective implantable catheter solutions. Wellink Medical has established a notable presence in the UK Catheters Active Implantable CDMO Market, highlighting its strengths in innovation and advanced manufacturing capabilities. The company's focus on developing cutting-edge products tailored to the specific needs of its clients has garnered recognition in the industry. Wellink Medical leverages its expertise in regulatory navigation, ensuring compliance with stringent UK health and safety standards, while also emphasizing quality assurance throughout its production processes.  The company has built a reputation for its reliability and responsiveness, positioning itself as a key partner for healthcare providers and medical device manufacturers seeking high-quality catheter solutions. Its unwavering commitment to research and development enhances its competitive edge, allowing it to tailor its offerings to meet evolving market demands and customer expectations.In the UK Catheters Active Implantable CDMO Market, Boston Scientific has emerged as a significant player, boasting an extensive portfolio of innovative products and services.  The company provides a broad range of catheter-based therapies that address various medical conditions, showcasing its strengths in research, development, and sophisticated manufacturing techniques. Boston Scientific is well-regarded for its ability to integrate advanced technology into its product offerings, making significant contributions to improving patient outcomes in the region. With active pursuits in mergers and acquisitions, Boston Scientific has strategically expanded its market reach in the UK, enhancing its capabilities and resources to meet growing demand. The company's emphasis on continuous innovation and adaptability, combined with its established distribution channels and strong partnerships within the healthcare ecosystem, secures its position as a competitive powerhouse in the UK Catheters Active Implantable CDMO Market. **Key Companies in the UK Catheters Active Implantable CDMO Market Include:** **UK Catheters Active Implantable CDMO Market Industry Developments** The UK Catheters Active Implantable Contract Development and Manufacturing Organization (CDMO) Market is currently experiencing notable developments. Recently, Wellink Medical announced advancements in their catheter technologies, enhancing patient outcomes and operational efficiency. Boston Scientific continues to expand its portfolio with innovative implantable devices designed for cardiac and urological applications. Meanwhile, Medtronic has been focusing on strategic partnerships to leverage emerging technologies in the active implantable sector. Noteworthy mergers have been unfolding; for example, Abbott Laboratories completed its acquisition of a small firm specializing in catheter-related diagnostics in June 2023, further strengthening its market position.  Teleflex has also been advancing its capabilities after acquiring a prominent medical device company last year, aiming to enhance its product offerings in the Active Implantable segment. The market valuation for key players such as AngioDynamics and Smiths Medical has shown significant growth over recent years, supported by increased surgical procedures and an aging population in the UK. In light of these developments, the regulatory landscape is adapting, with the UK government emphasizing the importance of Quality Management Systems in medical device manufacturing, which is expected to impact CDMO operations positively. ## **UK Catheters Active Implantable CDMO Market Segmentation Insights** ### **Catheters Active Implantable CDMO Market Service Category****Outlook** ### **Catheters Active Implantable CDMO Market End-Users****Outlook** ## Market Drivers ### Growing Prevalence of Chronic Diseases The catheters active-implantable-cdmo market is significantly influenced by the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and renal failure in the UK. As these conditions become more common, the demand for effective treatment options, including catheter-based interventions, is expected to rise. According to recent statistics, approximately 3.5 million people in the UK are living with diabetes, which necessitates the use of catheters for insulin delivery and other therapeutic applications. This growing patient population is likely to drive the expansion of the catheters active-implantable-cdmo market, as healthcare providers seek reliable solutions to manage chronic conditions effectively. ### Technological Innovations in Catheter Design The catheters active-implantable-cdmo market is witnessing a wave of technological innovations that enhance the performance and safety of catheters. Advancements such as biocompatible materials, smart catheters with integrated sensors, and improved delivery systems are transforming the landscape of catheter technology. These innovations not only improve patient outcomes but also reduce the risk of complications associated with catheter use. In the UK, the introduction of next-generation catheters is expected to capture a significant market share, as healthcare professionals increasingly adopt these advanced solutions. The continuous evolution of catheter design is likely to play a crucial role in shaping the future of the catheters active-implantable-cdmo market. ### Rising Demand for Minimally Invasive Procedures The catheters active-implantable-cdmo market experiences a notable surge in demand due to the increasing preference for minimally invasive procedures among healthcare providers and patients. This trend is driven by the advantages of reduced recovery times, lower risk of complications, and enhanced patient comfort. In the UK, the market for minimally invasive surgeries is projected to grow at a CAGR of approximately 8% over the next few years. As a result, manufacturers of catheters are focusing on developing advanced products that cater to this demand, thereby propelling the growth of the catheters active-implantable-cdmo market. The shift towards these procedures is likely to continue, influencing the design and functionality of catheters to meet evolving clinical needs. ### Increased Investment in Healthcare Infrastructure The catheters active-implantable-cdmo market benefits from the UK government's commitment to enhancing healthcare infrastructure. Recent investments aimed at modernizing hospitals and expanding healthcare facilities are expected to create a more conducive environment for the adoption of advanced medical devices, including catheters. The UK healthcare sector has seen an increase in funding, with an allocation of £20 billion for health services over the next five years. This financial support is likely to facilitate the procurement of innovative catheter technologies, thereby stimulating growth in the catheters active-implantable-cdmo market. Enhanced infrastructure not only improves patient access to care but also encourages the integration of cutting-edge medical devices into clinical practice. ### Focus on Regulatory Compliance and Quality Standards The catheters active-implantable-cdmo market is heavily influenced by the stringent regulatory environment in the UK. Regulatory bodies such as the Medicines and Healthcare products Regulatory Agency (MHRA) enforce rigorous quality standards for medical devices, including catheters. Compliance with these regulations is essential for manufacturers aiming to enter the market. The emphasis on quality assurance and safety is likely to drive innovation, as companies invest in research and development to meet regulatory requirements. This focus on compliance not only enhances product reliability but also fosters consumer trust in catheter technologies, thereby supporting the growth of the catheters active-implantable-cdmo market. ## Future Outlook The [Catheters Active Implantable CDMO Market](https://www.marketresearchfuture.com/reports/catheters-active-implantable-cdmo-market-26788) is projected to grow at 11.17% CAGR from 2025 to 2035, driven by technological advancements, increasing healthcare demands, and regulatory support. **New opportunities:** - Development of customized catheter solutions for niche medical applications. - Expansion of telehealth services integrating catheter management. - Investment in biodegradable materials for sustainable catheter production. By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic partnerships. ## Segment Insights ### By Service Segment: Catheters (Largest) vs. Active Implantable Devices (Fastest-Growing) In the UK catheters active-implantable-cdmo market, the service segment shows a significant distribution among catheters, active implantable devices, and endoscopy devices. Catheters hold the largest share due to their extensive clinical applications, particularly in critical patient care settings. Active implantable devices, on the other hand, are emerging robustly, driven by innovations in technology and increasing chronic disease prevalence, reflecting a dynamic shift in healthcare needs. Growth trends in this segment are propelled by advancements in materials and techniques, fostering the development of innovative catheter solutions and active implantable devices. The demand for minimally invasive procedures is influencing a shift towards these products, as healthcare providers strive for greater efficiency and patient comfort. Furthermore, increasing geriatric populations and a rise in procedures requiring endoscopy capabilities are pushing these segments into the spotlight, indicating a promising future for the service segments. Catheters (Dominant) vs. Endoscopy Devices (Emerging) Catheters are the dominant players in the UK catheters active-implantable-cdmo market, primarily due to their versatility and necessity in various medical procedures, including surgeries and long-term treatments. They are designed to provide effective and safe access for medication delivery and fluid management. On the other hand, endoscopy devices are considered emerging products, gaining traction as they become vital for diagnostic and therapeutic procedures. The shift towards minimally invasive surgeries is boosting the adoption of endoscopy devices. Together, these segments highlight a progressive approach in the medical field, indicating a shift towards improved patient outcomes and operational efficiencies. ### By End User: Medical Device OEM Companies (Largest) vs. Government Agencies (Fastest-Growing) The market for catheters in the active-implantable-cdmo sector shows a well-defined distribution of shares among major end users. Medical Device OEM Companies currently lead with substantial market dominance, reflecting their pivotal role in product innovation and development within the space. Academic and Research Institutes hold a smaller yet significant share, driven by their research initiatives and collaborative projects with OEMs. Government Agencies, while trailing in share, are increasingly expanding their influence in regulatory enhancements and funding for innovative medical solutions. Growth trends reveal a compelling narrative for the UK catheters active-implantable-cdmo market. The dominance of Medical Device OEM Companies is supported by continuous advancements in catheter technologies and materials. Conversely, the rise of Government Agencies as a fast-growing segment is fueled by enhanced regulatory frameworks and increased investment in healthcare infrastructure. Overall, as technological advancements and funding initiatives continue, the landscape for end users in this market appears promising and dynamic. Medical Device OEM Companies (Dominant) vs. Government Agencies (Emerging) Medical Device OEM Companies are characterized by their established market presence and innovation in the field. These companies are instrumental in the development and production of high-quality catheter devices, leveraging advanced technologies to meet clinical demands. Their robust manufacturing capabilities and extensive distribution networks position them as market leaders. On the other hand, Government Agencies are emerging as critical players, tasked with overseeing regulations and ensuring patient safety. Their involvement in funding essential research and the implementation of health policies drives growth, indicating a shift toward collaborative efforts between the public sector and private enterprises within the UK catheters active-implantable-cdmo market. ## Competitive Benchmarking The catheters active-implantable-cdmo market in the UK is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on regulatory compliance. Key players such as Medtronic (US), Boston Scientific (US), and Abbott (US) are at the forefront, leveraging their extensive research and development capabilities to enhance product offerings. Medtronic (US) emphasizes a strategy centered on technological advancements, particularly in minimally invasive procedures, which aligns with the growing demand for less invasive treatment options. Meanwhile, Boston Scientific (US) focuses on expanding its product portfolio through strategic acquisitions, thereby enhancing its market presence and operational capabilities. Abbott (US) appears to be concentrating on digital health solutions, integrating advanced data analytics into its catheter technologies, which may provide a competitive edge in patient monitoring and outcomes.The business tactics employed by these companies reflect a trend towards localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The market structure is moderately fragmented, with several players vying for market share, yet the collective influence of these key companies is substantial. Their strategies not only drive innovation but also set benchmarks for quality and performance in the industry, thereby shaping the competitive dynamics. In September Medtronic (US) announced the launch of a new catheter designed for cardiac procedures, which incorporates advanced materials aimed at reducing complications. This strategic move is significant as it not only addresses the increasing demand for safer medical devices but also reinforces Medtronic's commitment to innovation in the cardiovascular space. Similarly, in October 2025, Boston Scientific (US) completed the acquisition of a smaller firm specializing in catheter technology, which is expected to enhance its product offerings and market reach. This acquisition underscores the importance of strategic growth through consolidation in a competitive market. In August Abbott (US) unveiled a new digital platform that integrates with its catheter systems, allowing for real-time data collection and analysis. This initiative is indicative of a broader trend towards digitalization in the healthcare sector, potentially improving patient outcomes and operational efficiencies. Such advancements not only position Abbott as a leader in technological integration but also reflect the industry's shift towards data-driven decision-making. As of November the competitive trends in the catheters active-implantable-cdmo market are increasingly defined by digital transformation, sustainability initiatives, and the integration of artificial intelligence. Strategic alliances among key players are becoming more prevalent, facilitating knowledge sharing and resource optimization. The competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. Companies that can effectively navigate these trends may secure a more robust position in the market, ultimately enhancing their long-term viability and success. ## Recent News & Developments The UK Catheters Active Implantable Contract Development and Manufacturing Organization (CDMO) Market is currently experiencing notable developments. Recently, Wellink Medical announced advancements in their catheter technologies, enhancing patient outcomes and operational efficiency. Boston Scientific continues to expand its portfolio with innovative implantable devices designed for cardiac and urological applications. Meanwhile, Medtronic has been focusing on strategic partnerships to leverage emerging technologies in the active implantable sector. Noteworthy mergers have been unfolding; for example, Abbott Laboratories completed its acquisition of a small firm specializing in catheter-related diagnostics in June 2023, further strengthening its market position.  Teleflex has also been advancing its capabilities after acquiring a prominent medical device company last year, aiming to enhance its product offerings in the Active Implantable segment. The market valuation for key players such as AngioDynamics and Smiths Medical has shown significant growth over recent years, supported by increased surgical procedures and an aging population in the UK. In light of these developments, the regulatory landscape is adapting, with the UK government emphasizing the importance of Quality Management Systems in medical device manufacturing, which is expected to impact CDMO operations positively. ## Report Scope | MARKET SIZE 2024 | 280.88(USD Million) | | --- | --- | | MARKET SIZE 2025 | 312.25(USD Million) | | MARKET SIZE 2035 | 900.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 11.17% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Boston Scientific (US), Abbott (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Cook Medical (US), Terumo Corporation (JP), Smiths Medical (US), Halyard Health (US) | | Segments Covered | Service Segment, End User | | Key Market Opportunities | Advancements in biocompatible materials enhance innovation in the catheters active-implantable-cdmo market. | | Key Market Dynamics | Rising demand for innovative catheter technologies drives competition among active-implantable contract development and manufacturing organizations. | | Countries Covered | UK | ## Frequently Asked Questions **Q: What was the overall market valuation of the UK catheters active-implantable-cdmo market in 2024?** A: The overall market valuation was 280.88 $ Million in 2024. **Q: What is the projected market valuation for the UK catheters active-implantable-cdmo market by 2035?** A: The projected valuation for 2035 is 900.0 $ Million. **Q: What is the expected CAGR for the UK catheters active-implantable-cdmo market during the forecast period 2025 - 2035?** A: The expected CAGR during the forecast period 2025 - 2035 is 11.17 %. **Q: Which companies are considered key players in the UK catheters active-implantable-cdmo market?** A: Key players include Medtronic, Boston Scientific, Abbott, Johnson & Johnson, B. Braun Melsungen AG, Cook Medical, Terumo Corporation, Smiths Medical, and Halyard Health. **Q: What were the segment valuations for catheters in the service segment in 2024?** A: In 2024, the segment valuation for catheters in the service segment was between 80.0 and 250.0 $ Million. **Q: What is the valuation range for active implantable devices in the service segment?** A: The valuation range for active implantable devices in the service segment was between 100.0 and 350.0 $ Million in 2024. **Q: What were the segment valuations for endoscopy devices in the service segment in 2024?** A: The segment valuation for endoscopy devices in the service segment was between 100.88 and 300.0 $ Million in 2024. **Q: What is the valuation range for medical device OEM companies as end users in 2024?** A: The valuation range for medical device OEM companies as end users was between 112.35 and 360.0 $ Million in 2024. **Q: What were the valuations for academic and research institutes as end users in 2024?** A: The valuations for academic and research institutes as end users ranged from 84.66 to 270.0 $ Million in 2024. **Q: What was the valuation range for government agencies as end users in 2024?** A: The valuation range for government agencies as end users was between 83.87 and 270.0 $ Million in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/uk-catheters-active-implantable-cdmo-market-50126*